Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAP Regimen in Locally Advanced TNBC
NCT03304756Phase 2Completed
- Sponsor
- Instituto Nacional de Câncer José Alencar Gomes da Silva
- Start
- Dec 2007
- Primary completion
- Apr 2012
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of cisplatin in triple-negative breast cancer (TNBC), sponsored by Instituto Nacional de Câncer José Alencar Gomes da Silva. Started Dec 2007; status: completed.
02
Drugs
cisplatin
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT03304756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03304756.